Installé dans l’appartement où Louis Pasteur passa les sept dernières années de sa vie, le musée Pasteur constitue une occasion unique de pénétrer dans l’univers de l’illustre savant : de visualiser sa vie au quotidien aux côtés de son épouse et de traverser son œuvre scientifique abondante.
Faire un don à l’Institut Pasteur, c’est contribuer aux avancées de ses recherches biomédicales et être ainsi associé à ses chercheurs et à leurs découvertes sur les cancers, les maladies du cerveau, les maladies infectieuses, et bien d’autres encore…
L’ambition scientifique de l’Institut Pasteur exige une organisation de la recherche qui accompagne et soutienne ses priorités. Aujourd’hui structuré en départements, l’Institut Pasteur a entamé une transformation ambitieuse de l’organisation de sa recherche sous le signe de la transversalité, de ...
Le Centre médical de l’Institut Pasteur est un centre de santé conventionné secteur 1. Il propose une offre de soin à destination des voyageurs, et la prise en charge diagnostique et thérapeutique des maladies infectieuses, tropicales et allergiques. Le Centre médical de l’Institut Pasteur, ...
Depuis la création du premier cours de « microbie technique » en 1889, l’enseignement reste une priorité pour l’Institut Pasteur. Reconnu au niveau international, la qualité de l’enseignement de l’Institut Pasteur lui permet d’accueillir chaque année des ...
La Direction des applications de la recherche et relations industrielles (DARRI) a pour mission de détecter, promouvoir, protéger, commercialiser et gérer les innovations émergeant du campus de l’Institut Pasteur. Elle vise à établir des coopérations fructueuses avec des partenaires industriels et ...
Cours, thèses, stages postdoctoraux chaque institut du Réseau International des Instituts Pasteur (RIIP) contribue à la transmission des savoirs pour permettre dans toutes les régions du monde la formation des chercheurs et experts en santé publique de demain. Dans ce cadre, les programmes ...
a) The study of the homeostatic mechanisms that control B and T cell numbers.
b) The study of the mechanisms of lymphocyte survival: the rates of production, renewal and death.
c) The study of the role of lymphocyte competition in the selection and control of the primary and memory immune responses.
B cell homeostasis and selection of IgM-secreting cells (Yi Hao).
We have studied the role of BM B cell production in the renewal of peripheral B cells and the feedback mechanisms that control the entry of newly formed B cells into the peripheral B cell pools. When resting lymph node B cells are injected into B cell deficient hosts a fraction of the transferred cells expands and constitute a highly selected population which survives for prolonged periods of time by continuous cell renewal at the periphery. Although the number of donor B cells recovered is low, a significant fraction shows an activated phenotype and the serum IgM levels are as in normal mice. This population of activated B cells is resistant to replacement by a new cohort of B cells and is able to feedback regulate both the entry of newly formed B cells into the peripheral pool and terminal differentiation. These findings suggest that peripheral B cell selection follows the rule “first come, first served” and that IgM-secreting cells are generated from a pool of stable activated B cells with an independent homeostasis.
We questioned whether Ig secretion by the first population was responsible for the feedback effect observed. To test this hypothesis we used B cells from mutant mice, which are unable to secrete IgM. Our findings indicate that IgM secretion is not determinant in the feedback effect. We are currently testing alternative mechanisms. These experiments were done in collaboration with Dr. M. Ehrenstein (London).
Toll-like Receptor 9 controls key checkpoints of B lymphocyte development (Yi Hao).
Toll-like receptors are involved in the expansion of autoreactive B lymphocytes. In collaboration with Drs. J.P. Pereira and P. Vieira (U. Dev. Lymph., Inst. Pasteur) we showed that the immature B cell compartment of young, but not adult, TLR9-deficient mice developed earlier than that of C57BL/6 mice. By a competitive repopulation strategy we showed that TLR9 signaling is necessary at key checkpoints of the murine B cell developmental program, selection into secondary lymphoid organs, and differentiation into Ig-secreting plasma cells.
CD8 T cell survival (Yi Hao).
In collaboration with Nicolas Legrand we continued to compare the MHC requirements for the survival of several monoclonal CD8+ T cells expressing different TCR specificities and phenotypes, by following T cell fate upon transfer into T cell deficient mice lacking selective MHC class I molecules. We found that while the survival of naïve aHY and P14 CD8+ T cells strictly require the presence of the H-2Db restricting element, OT-1 can survive in absence of its H-2Kb restricting element and even in complete absence of any MHC class I molecule. We also studied the possible role of MHC class I as a resource by following the fate of monoclonal CD8+ T cells in mouse BM chimeras containing limited numbers of MHC class I expressing cells. We found that the number of MHC-expressing cells and the ability of the TCR to recognize different MHC molecules determine CD8+ T cell survival and the size of the peripheral pool. Since these different capacities control clone size and niche formation, they likely have a major role in the final composition of peripheral T cell repertoires. By comparing the fate of naive and activated/memory cell from diverse polyclonal CD8+ T cell populations in absence of MHC class I, we illustrate that cells expressing promiscuous TCRs are preferentially found in the “natural memory/activated pool”.
Role of the MHC-ligand/TCR interactions in the survival and LDO of CD8 T cells (Sylvie Garcia).
The involvement of TCR/MHC-peptide interactions in the survival of CD4 and CD8 naïve T cells is well documented. It has also been proposed lymphopenia driven proliferation (LDP) is controlled by specific TCR/MHC-peptide interactions. In both cases, these interactions would be of weak affinity and similar of those involved during thymic positive selection. Nevertheless, the nature of these interactions and the overlapping between those involved in the survival vs. LDP of T cells is unknown.
In order to answer this question, we have used a model consisting of injecting CFSE labeled polyclonal CD8 T cells into Rag-/- hosts or OT-1 Rag-/- hosts transgenic for a Class I-restricted OVA-specific TCR. While virtually all T cells resulted of 8 divisions or more (CFSE-) 4 to 5 weeks after transfer into Rag2-/- hosts, in OT-1 hosts a fraction of the donor cells did not proliferate and remained CFSE+ and CD44lo. We studied whether the absence of proliferation of the CFSE+ cells was to due to a lack of “unspecific” (cytokines for example) or/and “specific” (MHC-ligand interactions) resources. CD8 T cells which remained CFSE+ were sorted and re-transferred into different secondary hosts. We found that while they divided in rag2-/- hosts excluding an intrinsic proliferative defect, they were still unable to proliferate in OT-1 hosts. Interestingly, these cells divided after transfer into other P14 hosts expressing a transgenic TCR class I-restricted and specific for the gp33 of LCMV. In these hosts, expansion was similar to that observed in rag-/- hosts, suggesting that these T cells may require “specific” MHC-peptide/TCR interactions to proliferate similar to those required by OT-1 T cells to survive. When co-transferred together with OT-1 T cells into rag2-/- hosts, the CFSE+ CD8 T cells out-compete OT-1 T cells, suggesting than here again CFSE+ T cells require “specific” MHC-peptide interactions to proliferate similar to those required by OT-1 T cells for LDP. Altogether, these findings indicate that the TCR/MHC-peptide interactions involved in the survival and the LDP of OT-1 T cells overlap. They provide a relevant molecular basis to the occurrence of “spontaneous” auto-immune” lymphoproliferative disease in lymphopenic hosts engrafted with mature T cells.
Differential role of STAT proteins in the selection of antigen-specific of CD4+ T cells (Vanesa Guajardo).
The outcome of an immune response relies on the competitive capacities acquired through differentiation of CD4+ T cells into Th1 or Th2 effector cells. Because Stat4 and Stat6 proteins are implicated in the Th1 vs Th2 generation and maintenance, respectively, we compare in this study the kinetics of Stat4-/- and Stat6-/- CD4+ T cells. We had previously found that during LDP, T cells activated the Stat4 pathway and down-regulated Stat6, which conferred to Stat6-/- T cells a slight proliferation advantage that in a competitive situation had major late repercussions, because it modified the final homeostatic equilibrium of the populations and favoured the establishment of Th1-like CD4+ T cell dominance.
To further investigate if the observed proliferative advantage was also seen when CD4+ T cells were primed by cognate antigen, we crossed our Stat deficient mice with TCR transgenic mice specific for virus' hemagglutinin (TCR HA, peptide 111-119). Peripheral transfer of TCR HA+ Stat-/- cells into lymphopenic mice, lacking or expressing cognate antigen, revealed that the proliferative advantage seen in the Stat6-/- T cell population was kept when primed by its specific antigen. TCR HA+ Stat6-/- cells attaining a higher plateau than their Stat4-/- counterparts and out-compete them when co-transferred. We then proceeded to analyze the effect of antigen presence during thymus T cell development. To this effect we made BM chimeras of irradiated hosts expressing or lacking the HA peptide and BM from Stat6-/- and/or Stat4-/- TCR HA Rag2-/-. Under these conditions, TCR HA+ Stat6-/- cells only show a proliferative advantage, have higher number of peripheral CD4+ cells, in chimeras expressing antigen. Furthermore, the presence of antigen results in the accumulation of CD25 FoxP3+ CD4+ T cells of Stat4-/- origin, suggesting that the Stat pathways are involved in CD4+ T cell development and implicating them for the first time in the modulation of Treg development.
Competition and survival among memory T cells (Catarina Leitao, Sylvie Garcia).
The survival competitive properties of memory T cells are one of the parameters that control the composition of the memory compartments. The aim of this project is to define and compare the rules governing the CD4 and CD8 memory pool. The capacities of newly generated T cell memory subpopulation to out-compete preexistent T cell memory subsets has been observed during LCMV infection. This out-competition was only shown for the CD8 compartment and not for the CD4 compartment. This process lead to the qualitative impoverishment of the memory pool (named attrition). We ask: 1- whether CD4 memory is also affected by attrition during bacterial infections. 2- the role of inflammatory signals in this process. To address these issues, we are creating mice containing several TCR tg T cell CD4 and CD8 subsets and polyclonal T cells. This is achieved either by engraftments of a mixture BM precursors or adoptive transfers of mature T cells into T cell deficient hosts. In these mice, each subsets can be easily distingued by the differential expression of Va, Vb and Ly5 and Thy1 alleles. Sequential immunizations of the different TCR transgenic naïve T cell subsets contained in the hosts are performed. The fate of each memory subsets is followed regarding to the specificity, function (Th1 vs Th2 for CD4 memory) and age of memory cells. These studies should help to understand the regulatory processes controlling the generation and maintenance of the memory T cell pool during acute (i.e. vaccination) or chronic (i.e. HIV infection) antigenic stimulations.
Keywords : B cells, T cells, lymphocyte homeostasis, lymphocyte survival, immunological memory